Drug Shortage Report for BRIMONIDINE P
| Report ID | 162446 |
| Drug Identification Number | 02301334 |
| Brand name | BRIMONIDINE P |
| Common or Proper name | Brimonidine P |
| Company Name | AA PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | BRIMONIDINE TARTRATE |
| Strength(s) | 0.15% |
| Dosage form(s) | SOLUTION |
| Route of administration | OPHTHALMIC OPHTHALMIC |
| Packaging size | 10ML |
| ATC code | S01EA |
| ATC description | ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2022-06-30 |
| Actual start date | |
| Estimated end date | 2022-10-27 |
| Actual end date | 2022-06-17 |
| Shortage status | Avoided shortage |
| Updated date | 2022-06-17 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2022-06-17 | French | Compare |
| v3 | 2022-06-17 | English | Compare |
| v2 | 2022-06-10 | French | Compare |
| v1 | 2022-06-10 | English | Compare |
Showing 1 to 4 of 4